Global /China /Healthcare /Biotechnology /603127
chevron_leftBack
Joinn Laboratories(China)Co.,Ltd. logo

Joinn Laboratories(China)Co.,Ltd.

603127
SSE: 603127 Delayed
38.87CNY 0.6%
5.74 USD
As of 15 June 2026, Joinn Laboratories(China)Co.,Ltd. has a market cap of $3.9B USD, ranking #4541 globally and #926 in China. It ranks #347 in the Healthcare sector, and #61 in the Biotechnology industry.
Global Rank
4541
Country Rank
926
Sector Rank
347
Industry Rank
61
Key Stats
Market Cap
$3.9BUSD
26.39B CNY
Enterprise Value
$3.4BUSD
22.99B CNY
Revenue (TTM)
$244.94MUSD
1.66B CNY
EBITDA (TTM)
-$3.62MUSD
-24.51M CNY
Net Income (TTM)
$44.01MUSD
297.84M CNY
EBITDA Margin
-1.5%
Profit Margin
18%
PE Ratio
96.6
Forward PE
72.6
PS Ratio
15.9
PB Ratio
3.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Dapeng Gao open_in_new
Employees
2,649
Founded
1995
Website
joinnlabs.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.6% 3.6% 28% 3.3% 11% 149%

News

Loading...

Markets

Exchange Ticker Price
Shanghai Stock Exchange
MIC: XSHG
PRIMARY
603127
北京昭衍新药研究中心股份有限公司 Class A
ISIN: CNE100002W27
Shares Out.:
614.231M1 Shares Float: 346.617M2
TV:
SA:
YF:
GF:
BA:
MS:
38.87 CNY
Hong Kong Stock Exchange
MIC: XHKG
6127
北京昭衍新药研究中心股份有限公司 Class H
ISIN: CNE100004BP3
Shares Out.:
118.995M1 Shares Float: 104.685M2
TV:
SA:
YF:
GF:
BA:
MS:
21.50 HKD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Joinn Laboratories(China)Co.,Ltd.

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment engages in the design, production, breeding, and sale of research models, including non-human primates and rodents. The company also offers cell-based assay (CBA) services. In addition, it offers drug quality research and testing services for protein drugs, vaccines, gene and cell therapy products, and provides customized solutions for early-stage drug discovery, screening, and mechanism research. Joinn Laboratories(China)Co.,Ltd. was incorporated in 1995 and is headquartered in Beijing, China.

Similar Companies

Industry: Biotechnology (China)
Name
Market Cap diff.
PE
$17.45B
136.71B HKD
347%
25.3
$12.2B
95.58B HKD
213%
22.1
$8.01B
54.23B CNY
106%
34.4
$7.34B
49.69B CNY
88%
-
1530
$7.08B
55.5B HKD
82%
5.8
$6.73B
45.52B CNY
73%
61.6
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
5K%
23.9
GILD
$159.92B
4K%
19.0
ARGX
$47.84B
41.39B EUR
1K%
39.9
$44.92B
68.19T KRW
1K%
35.5
CSL
$42.46B
60.27B AUD
989%
29.3
LONN
$42.3B
33.71B CHF
985%
37.2
chevron_leftBack